» Articles » PMID: 8125145

A Simple Assay for Detection of Peptides Promoting the Assembly of HLA Class I Molecules

Overview
Journal Eur J Immunol
Date 1994 Mar 1
PMID 8125145
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Synthetic peptides derived from influenza virus and human immunodeficiency virus were tested for their ability to promote the assembly of HLA-A2 and HLA-B51 molecules in T2 cell lysates. Specific assembly was detected by an enzyme-linked immunosorbent assay. The most significant HLA-A2 assembly was obtained in the presence of peptides known to be targets for HLA-A2-restricted cytotoxic T lymphocytes (influenza matrix M.58-66 and HIV Pol 476-484). Three of a batch of Nef peptides corresponding to epitopic regions for cytotoxic T lymphocytes, caused significant assembly of HLA-A2 (Nef 83-91, 137-145 and 144-153), but only at high concentrations (100 microM). As these peptides bound relatively weakly, it is unlikely that they are good candidates for HLA-A2-restricted CTL epitopes. Peptides matrix M.60-68, Nef 186-194, and Plasmodium falciparum sh.77-85 produced the most significant assembly of HLA-B51. These peptides have a dominant hydrophobic anchor residue (V, L. I) at position 9 that could occupy pocket "F". Our results also suggest that another hydrophobic residue (V, L) at position 3 or 4 may anchor to hydrophobic pocket "D" of HLA-B51. Proline at position 2 greatly increases HLA-B51 anchoring.

Citing Articles

Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins.

Bourgault Villada I, Moyal Barracco M, Berville S, Bafounta M, Longvert C, Premel V Clin Exp Immunol. 2009; 159(1):45-56.

PMID: 19843089 PMC: 2802693. DOI: 10.1111/j.1365-2249.2009.04006.x.


T cell response to Hu-D peptides in patients with anti-Hu syndrome.

Rousseau A, Benyahia B, Dalmau J, Connan F, Guillet J, Delattre J J Neurooncol. 2005; 71(3):231-6.

PMID: 15735910 PMC: 2586925. DOI: 10.1007/s11060-004-1723-1.


Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.

Andrieu M, Desoutter J, Loing E, Gaston J, Hanau D, Guillet J J Virol. 2002; 77(2):1564-70.

PMID: 12502869 PMC: 140847. DOI: 10.1128/jvi.77.2.1564-1570.2003.


Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.

Cohen W, Bianco A, Connan F, Camoin L, Dalod M, Lauvau G J Virol. 2002; 76(20):10219-25.

PMID: 12239297 PMC: 136577. DOI: 10.1128/jvi.76.20.10219-10225.2002.


Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine.

Gahery-Segard H, Pialoux G, Charmeteau B, Sermet S, Poncelet H, Raux M J Virol. 2000; 74(4):1694-703.

PMID: 10644339 PMC: 111644. DOI: 10.1128/jvi.74.4.1694-1703.2000.